An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder
An open trial of a transdiagnostic cognitive-behavioral group therapy for anxiety disorder
复制标题
DOI：
10.1016/j.beth.2007.08.002
复制
发表时间：
2008-09-01
期刊：
影响因子：
3.7
通讯作者：
Norton, Peter J.
中科院分区：
文献类型：
--
作者：
Norton, Peter J.
近年来，焦虑的跨诊断模型和基于这些模型的认知行为治疗越来越受到关注。初步的疗效研究通常表明治疗效果很好，尽管这些研究中很少有研究不同焦虑症患者的治疗效果在多大程度上相似。当前研究的目的是检验为期12周的跨诊断组认知行为疗法对焦虑症的疗效，并比较不同诊断的结果。对52名参加公开结果试验的焦虑障碍（主要是惊恐障碍和社交恐惧症）参与者的数据进行混合效应回归建模，结果表明，参与者倾向于治疗后改善，没有任何原发性或共病性障碍的差异结果。本研究的结果为跨诊断焦虑治疗模型提供了越来越多的证据基础，并为不同焦虑诊断的个体可以在相同的治疗方案中得到平等对待的假设提供了初步支持。
Transdiagnostic models of anxiety, and cognitive-behavioral treatments based on these models, have been gaining increased attention in recent years. Preliminary efficacy studies generally suggest strong treatment effects, although few of these studies have examined to what extent treatment effects are similar across clients with different anxiety disorders. The purpose of the current study was to examine the efficacy of a 12-week transdiagnostic group cognitive-behavioral therapy for anxiety disorders and compare outcome across diagnoses. Mixed-effect regression modeling of data from 52 participants with anxiety disorders (predominantly panic disorder and social phobia) participating in an open outcome trial indicated that participants tended to improve over treatment, with no differential outcome for any primary or comorbid disorders. The results of this study add to the growing evidence base for transdiagnostic anxiety treatment models and provide preliminary support for the assumption that individuals with different anxiety diagnoses can be treated equally within the same treatment protocol.